title: Pharmacologic targets and peritoneal membrane remodeling.
abstract: Peritoneal dialysis (PD) is associated with functional and structural changes of the peritoneal membrane, also known as peritoneal remodeling. The peritoneal membrane is affected by many endogenous and exogenous factors such as cytokines, PD fluids, and therapeutic interventions. Here, we present an overview of various studies that have investigated pharmacologic interventions aimed at regression of peritoneal damage and prolongation of PD treatment.
authors: Department of Nephrology,1 VU University Medical Center, and Department of Molecular Cell Biology and Immunology,2 VU University, Amsterdam, Netherlands.
authors: Karima
authors: K
authors: Farhat
authors: Andrea W D
authors: AW
authors: Stavenuiter
authors: Rob H J
authors: RH
authors: Beelen
authors: Piet M
authors: PM
authors: Ter Wee
mesh_terms: D006801:Humans; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D056627:Peritoneal Fibrosis / Q000209:etiology / Q000517:prevention & control; D010537:Peritoneum / Q000187:drug effects* / Q000473:pathology*; D010538:Peritonitis / Q000209:etiology / Q000517:prevention & control
keywords: Therapeutic interventions